Loading…
Serum CD40L, ST2, IL-6, and CRP serving as biomarkers for acute coronary syndrome
To analyze the diagnostic value of CD40 ligand (CD40L), soluble growth stimulating expression gene 2 protein (ST2), interleukin-6 (IL-6), and C-reactive protein (CRP) are used in patients with acute coronary syndrome (ACS). Serum samples were collected from 259 ACS patients admitted to our hospital....
Saved in:
Published in: | European journal of inflammation 2022-03, Vol.20 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53 |
---|---|
cites | cdi_FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53 |
container_end_page | |
container_issue | |
container_start_page | |
container_title | European journal of inflammation |
container_volume | 20 |
creator | Zhu, Li Zhang, Chuanmeng Mao, Guangyao Xu, Jie Qian, Jingyu Jiang, Lin Ye, Jun |
description | To analyze the diagnostic value of CD40 ligand (CD40L), soluble growth stimulating expression gene 2 protein (ST2), interleukin-6 (IL-6), and C-reactive protein (CRP) are used in patients with acute coronary syndrome (ACS). Serum samples were collected from 259 ACS patients admitted to our hospital. Additionally, 119 healthy individuals who received physical examination in the hospital at the same time period were included as normal control. The levels of CD40L, ST2, IL-6, and CRP in 259 patients with ACS and 119 healthy subjects were detected by ELISA. The levels of CD40L, ST2, IL-6, and CRP were significantly increased in unstable angina (UA) patients, while ST2, CRP, and IL-6 were significantly elevated in acute myocardial infarction (AMI) patients. Pearson correlation analysis showed that ST2 was also closely related to CRP in ACS patients, while ST2 was positively correlated with creatine kinase (CK), creatine kinase isoenzyme (CK-MB), and troponin I (cTnI) in AMI patients. The levels of glucose (GLU) and low-density lipoprotein cholesterol (LDL-c) were significantly decreased, while the levels of high-density lipoprotein cholesterol (HDL-c) were significantly increased in AMI patients treated with stent implantation. Furthermore, the level of serum CD40 L was significantly elevated in coronary heart disease (CHD) patients treated with stent implantation, while the levels of ST2 and IL-6 in AMI patients treated with the stent implantation decreased significantly. The levels of inflammatory factors significantly changed in patients with ACS. These inflammatory factors may involve in the pathological progression of ACS and can be used as diagnostic indexes for ACS. |
doi_str_mv | 10.1177/20587392211051115 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a8a8cd6a6da249d883bf465b1badee0f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_20587392211051115</sage_id><doaj_id>oai_doaj_org_article_a8a8cd6a6da249d883bf465b1badee0f</doaj_id><sourcerecordid>2767415669</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53</originalsourceid><addsrcrecordid>eNp1kV9LIzEUxcOiYFE_gG-Bfe3o3GQmmTxK1z-Fgq51Yd_CneSmTLUTTVqh336nVtwH8b5cOJzzuwcuY2dQngNofSHKutHSCAFQ1gBQ_2CjnVbsxAM2Ai2g0EL_PWKnOS_LYZRQ2jQj9ntOabPik19VORvz-aMY8-msUGOOveeTh3ueKb11_YJj5m0XV5ieKGUeYuLoNmviLqbYY9ryvO19iis6YYcBnzOdfuxj9uf66nFyW8zubqaTy1nhKgHrApBEIxQFV6kyeOeRSCryXkllKhekMZ4kmVaiccr4QC2JyqH3BqTxtTxm0z3XR1zal9QN3bY2YmffhZgWFtO6c89kscHGeYXKo6iMbxrZhkrVLbToicowsH7uWS8pvm4or-0yblI_1LdCK11BrZQZXLB3uRRzThQ-r0Jpd4-wXx4xZM73mYwL-k_9PvAPao-GmQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767415669</pqid></control><display><type>article</type><title>Serum CD40L, ST2, IL-6, and CRP serving as biomarkers for acute coronary syndrome</title><source>Publicly Available Content Database</source><source>Sage Journals GOLD Open Access 2024</source><creator>Zhu, Li ; Zhang, Chuanmeng ; Mao, Guangyao ; Xu, Jie ; Qian, Jingyu ; Jiang, Lin ; Ye, Jun</creator><creatorcontrib>Zhu, Li ; Zhang, Chuanmeng ; Mao, Guangyao ; Xu, Jie ; Qian, Jingyu ; Jiang, Lin ; Ye, Jun</creatorcontrib><description>To analyze the diagnostic value of CD40 ligand (CD40L), soluble growth stimulating expression gene 2 protein (ST2), interleukin-6 (IL-6), and C-reactive protein (CRP) are used in patients with acute coronary syndrome (ACS). Serum samples were collected from 259 ACS patients admitted to our hospital. Additionally, 119 healthy individuals who received physical examination in the hospital at the same time period were included as normal control. The levels of CD40L, ST2, IL-6, and CRP in 259 patients with ACS and 119 healthy subjects were detected by ELISA. The levels of CD40L, ST2, IL-6, and CRP were significantly increased in unstable angina (UA) patients, while ST2, CRP, and IL-6 were significantly elevated in acute myocardial infarction (AMI) patients. Pearson correlation analysis showed that ST2 was also closely related to CRP in ACS patients, while ST2 was positively correlated with creatine kinase (CK), creatine kinase isoenzyme (CK-MB), and troponin I (cTnI) in AMI patients. The levels of glucose (GLU) and low-density lipoprotein cholesterol (LDL-c) were significantly decreased, while the levels of high-density lipoprotein cholesterol (HDL-c) were significantly increased in AMI patients treated with stent implantation. Furthermore, the level of serum CD40 L was significantly elevated in coronary heart disease (CHD) patients treated with stent implantation, while the levels of ST2 and IL-6 in AMI patients treated with the stent implantation decreased significantly. The levels of inflammatory factors significantly changed in patients with ACS. These inflammatory factors may involve in the pathological progression of ACS and can be used as diagnostic indexes for ACS.</description><identifier>ISSN: 1721-727X</identifier><identifier>EISSN: 2058-7392</identifier><identifier>DOI: 10.1177/20587392211051115</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Acute coronary syndromes ; Biomarkers ; Cardiovascular disease ; Cytokines ; Proteins ; Stents</subject><ispartof>European journal of inflammation, 2022-03, Vol.20</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53</citedby><cites>FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53</cites><orcidid>0000-0002-1437-9694</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/20587392211051115$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2767415669?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,21966,25753,27853,27924,27925,37012,44590,44945,45333</link.rule.ids></links><search><creatorcontrib>Zhu, Li</creatorcontrib><creatorcontrib>Zhang, Chuanmeng</creatorcontrib><creatorcontrib>Mao, Guangyao</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Qian, Jingyu</creatorcontrib><creatorcontrib>Jiang, Lin</creatorcontrib><creatorcontrib>Ye, Jun</creatorcontrib><title>Serum CD40L, ST2, IL-6, and CRP serving as biomarkers for acute coronary syndrome</title><title>European journal of inflammation</title><description>To analyze the diagnostic value of CD40 ligand (CD40L), soluble growth stimulating expression gene 2 protein (ST2), interleukin-6 (IL-6), and C-reactive protein (CRP) are used in patients with acute coronary syndrome (ACS). Serum samples were collected from 259 ACS patients admitted to our hospital. Additionally, 119 healthy individuals who received physical examination in the hospital at the same time period were included as normal control. The levels of CD40L, ST2, IL-6, and CRP in 259 patients with ACS and 119 healthy subjects were detected by ELISA. The levels of CD40L, ST2, IL-6, and CRP were significantly increased in unstable angina (UA) patients, while ST2, CRP, and IL-6 were significantly elevated in acute myocardial infarction (AMI) patients. Pearson correlation analysis showed that ST2 was also closely related to CRP in ACS patients, while ST2 was positively correlated with creatine kinase (CK), creatine kinase isoenzyme (CK-MB), and troponin I (cTnI) in AMI patients. The levels of glucose (GLU) and low-density lipoprotein cholesterol (LDL-c) were significantly decreased, while the levels of high-density lipoprotein cholesterol (HDL-c) were significantly increased in AMI patients treated with stent implantation. Furthermore, the level of serum CD40 L was significantly elevated in coronary heart disease (CHD) patients treated with stent implantation, while the levels of ST2 and IL-6 in AMI patients treated with the stent implantation decreased significantly. The levels of inflammatory factors significantly changed in patients with ACS. These inflammatory factors may involve in the pathological progression of ACS and can be used as diagnostic indexes for ACS.</description><subject>Acute coronary syndromes</subject><subject>Biomarkers</subject><subject>Cardiovascular disease</subject><subject>Cytokines</subject><subject>Proteins</subject><subject>Stents</subject><issn>1721-727X</issn><issn>2058-7392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kV9LIzEUxcOiYFE_gG-Bfe3o3GQmmTxK1z-Fgq51Yd_CneSmTLUTTVqh336nVtwH8b5cOJzzuwcuY2dQngNofSHKutHSCAFQ1gBQ_2CjnVbsxAM2Ai2g0EL_PWKnOS_LYZRQ2jQj9ntOabPik19VORvz-aMY8-msUGOOveeTh3ueKb11_YJj5m0XV5ieKGUeYuLoNmviLqbYY9ryvO19iis6YYcBnzOdfuxj9uf66nFyW8zubqaTy1nhKgHrApBEIxQFV6kyeOeRSCryXkllKhekMZ4kmVaiccr4QC2JyqH3BqTxtTxm0z3XR1zal9QN3bY2YmffhZgWFtO6c89kscHGeYXKo6iMbxrZhkrVLbToicowsH7uWS8pvm4or-0yblI_1LdCK11BrZQZXLB3uRRzThQ-r0Jpd4-wXx4xZM73mYwL-k_9PvAPao-GmQ</recordid><startdate>20220309</startdate><enddate>20220309</enddate><creator>Zhu, Li</creator><creator>Zhang, Chuanmeng</creator><creator>Mao, Guangyao</creator><creator>Xu, Jie</creator><creator>Qian, Jingyu</creator><creator>Jiang, Lin</creator><creator>Ye, Jun</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1437-9694</orcidid></search><sort><creationdate>20220309</creationdate><title>Serum CD40L, ST2, IL-6, and CRP serving as biomarkers for acute coronary syndrome</title><author>Zhu, Li ; Zhang, Chuanmeng ; Mao, Guangyao ; Xu, Jie ; Qian, Jingyu ; Jiang, Lin ; Ye, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute coronary syndromes</topic><topic>Biomarkers</topic><topic>Cardiovascular disease</topic><topic>Cytokines</topic><topic>Proteins</topic><topic>Stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Li</creatorcontrib><creatorcontrib>Zhang, Chuanmeng</creatorcontrib><creatorcontrib>Mao, Guangyao</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Qian, Jingyu</creatorcontrib><creatorcontrib>Jiang, Lin</creatorcontrib><creatorcontrib>Ye, Jun</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>European journal of inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Li</au><au>Zhang, Chuanmeng</au><au>Mao, Guangyao</au><au>Xu, Jie</au><au>Qian, Jingyu</au><au>Jiang, Lin</au><au>Ye, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum CD40L, ST2, IL-6, and CRP serving as biomarkers for acute coronary syndrome</atitle><jtitle>European journal of inflammation</jtitle><date>2022-03-09</date><risdate>2022</risdate><volume>20</volume><issn>1721-727X</issn><eissn>2058-7392</eissn><abstract>To analyze the diagnostic value of CD40 ligand (CD40L), soluble growth stimulating expression gene 2 protein (ST2), interleukin-6 (IL-6), and C-reactive protein (CRP) are used in patients with acute coronary syndrome (ACS). Serum samples were collected from 259 ACS patients admitted to our hospital. Additionally, 119 healthy individuals who received physical examination in the hospital at the same time period were included as normal control. The levels of CD40L, ST2, IL-6, and CRP in 259 patients with ACS and 119 healthy subjects were detected by ELISA. The levels of CD40L, ST2, IL-6, and CRP were significantly increased in unstable angina (UA) patients, while ST2, CRP, and IL-6 were significantly elevated in acute myocardial infarction (AMI) patients. Pearson correlation analysis showed that ST2 was also closely related to CRP in ACS patients, while ST2 was positively correlated with creatine kinase (CK), creatine kinase isoenzyme (CK-MB), and troponin I (cTnI) in AMI patients. The levels of glucose (GLU) and low-density lipoprotein cholesterol (LDL-c) were significantly decreased, while the levels of high-density lipoprotein cholesterol (HDL-c) were significantly increased in AMI patients treated with stent implantation. Furthermore, the level of serum CD40 L was significantly elevated in coronary heart disease (CHD) patients treated with stent implantation, while the levels of ST2 and IL-6 in AMI patients treated with the stent implantation decreased significantly. The levels of inflammatory factors significantly changed in patients with ACS. These inflammatory factors may involve in the pathological progression of ACS and can be used as diagnostic indexes for ACS.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1177/20587392211051115</doi><orcidid>https://orcid.org/0000-0002-1437-9694</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1721-727X |
ispartof | European journal of inflammation, 2022-03, Vol.20 |
issn | 1721-727X 2058-7392 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_a8a8cd6a6da249d883bf465b1badee0f |
source | Publicly Available Content Database; Sage Journals GOLD Open Access 2024 |
subjects | Acute coronary syndromes Biomarkers Cardiovascular disease Cytokines Proteins Stents |
title | Serum CD40L, ST2, IL-6, and CRP serving as biomarkers for acute coronary syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A14%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20CD40L,%20ST2,%20IL-6,%20and%20CRP%20serving%20as%20biomarkers%20for%20acute%20coronary%20syndrome&rft.jtitle=European%20journal%20of%20inflammation&rft.au=Zhu,%20Li&rft.date=2022-03-09&rft.volume=20&rft.issn=1721-727X&rft.eissn=2058-7392&rft_id=info:doi/10.1177/20587392211051115&rft_dat=%3Cproquest_doaj_%3E2767415669%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-1ae2826efc460fdcdaee36edd63694cf399de3e9b3a9c69dfebe24cadd9139d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2767415669&rft_id=info:pmid/&rft_sage_id=10.1177_20587392211051115&rfr_iscdi=true |